- The first coronavirus vaccine developed by Moderna, to be tested on people in the US appears to be safe and able to stimulate an immune response against the virus.
- The volunteersmade antibodies that were then tested in human cells in the lab and were able to stop the virus from replicating — the key requirement for an effective vaccine.
- The levels of those so-called neutralising antibodies matched the levels found in patients who had recovered after contracting the virus.
- These initial results are based on tests of the low and medium doses. The only adverse effect at those doses was redness and soreness in one patient’s arm where the shot was given.